Just 1 week of full-dose ozanimod (Zeposia) was enough to bring symptom relief and biomarker improvement in patients with ulcerative colitis, a new analysis of placebo-controlled trial data indicated.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The oral ...

Massachusetts gastrointestinal disease firm, Cristcot, has announced results from its Phase III trial examining its hydrocortisone suppository and applicator for ulcerative colitis (UC), finding it to ...

Learn about common early signs of ulcerative colitis, including blood in stool, diarrhea, cramping, bloating, and bowel changes, for a prompt diagnosis and effective treatment.

Data from Digestive Disease Week showed that aspirin nearly doubled the risk for serious upper gastrointestinal bleeds in older adults. It was the top story in gastroenterology last week. Another top ...

Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...

Northwestern physicians use oxygen therapy to treat ulcerative colitis A group of physicians at Chicago-based Northwestern Medicine have started doing trials of hyperbaric oxygen therapy, a treatment ...

It can be overwhelming to receive a diagnosis of inflammatory bowel disease (IBD), a condition which refers to the chronic diseases that can cause inflammation in your gastrointestinal (GI) tract.